boston millennia partners
Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.
Boston Seed Capital
WE SEED INVEST. WE SEED ENTREPRENEURS. WE ARE BOSTON SEED. We are founders investing alongside founders who are striving to improve life, work, and play, through building innovative tech companies.
<br />
<br />
Consumer digital, sports & marketplaces, & AI, data & security are all fair game. And, above all, great entrepreneurs with great ideas.
Botswana Tech Fund
Botswana Tech Fund is a venture capital firm based in Southern Africa, focusing on investing in technology companies that are building Africa’s digital infrastructure. The firm is led by Managing Partner Martin Davis, an experienced technology operator with past leadership roles including CEO of FTSE 250–listed Molten Ventures. The team comprises seasoned investors and advisors with backgrounds in technology and corporate leadership, aiming to support startups through both capital and strategic guidance. The firm emphasizes long-term collaboration rather than just capital infusion.
Targeting sectors such as digital infrastructure, AI, blockchain, and finance technology, Botswana Tech Fund typically invests in a range of stages from pre-seed to Series C. They provide funding primarily across Southern Africa, with a thematic focus supporting both early-stage innovation and growth-stage scale. Their investment in this region addresses the funding gap in Southern African tech ecosystems, and they have strategic partnerships with local enterprise networks.
Notable companies in their portfolio include Revolut - global fintech service, Trustpilot - online review platform, Ledger - blockchain security, UiPath - automation software, and Bethnal Green Ventures - early-stage tech for good fund. They offer a blend of financial investment, strategic guidance, and regional expansion facilitation to founders.
Boulder Ventures
Boulder Ventures is a specialty venture capital firm, investing in a niche geography, leveraging decades long relationships with proven entrepreneurs and evaluating early stage companies with deep technical and scientific expertise.
We spend time and energy cultivating a network of serial entrepreneurs, because they are the source of Boulder Ventures investment ideas. Our serial entrepreneurs are subject matter experts. They consistently hatch market-leading ideas in information technology and life sciences that develop into market-leading companies in software, networking, data storage, drug discovery and tools, and technology enabled services.
Our model is to be the first professional investor in our portfolio companies, and to reserve capital to participate in multiple investment rounds. We capture value and a deal flow advantage by focusing our investments in two underserved geographies: Colorado and the Mid-Atlantic.
Boulder Ventures, with nearly 20 years of venture capital experience, continues to be a leading partner to serial entrepreneurs and a trusted advisor to our investors.
Boundary Holding
Boundary Holding is a specialized European venture capital firm that focuses on deep technology investments from its base in Europe. Founded by Rajat Khare, the firm is composed of a team of dedicated professionals who emphasize active scouting of promising technologies. What sets them apart is their proactive approach to identifying high-potential startups in the AI, robotics, and automation sectors, beyond the conventional in-bound pitch model seen in other firms.
The firm invests in a wide range of technologies enabling the 4th Industrial Revolution, such as smart robots, autonomous drones, and artificial intelligence. Investment sizes typically range from $0-1 million to $5-10 million, covering early-stage ventures through Series B. Though the specific firm establishment date isn't detailed, Boundary Holding operates with funds like Bridge Fund and PE Fund. Their geographical focus is primarily Europe, supporting companies that wish to scale within this unique regulatory environment.
Notable investments made by Boundary Holding include companies such as Greenovative - sustainable tech, Remidio - medical devices, TrashCon - waste management solutions, Vyntellig - data analytics, and Aero41 - drone technology. These investments reflect their focus on emerging technologies and their commitment to enabling innovative companies within Europe.
Bourne Avenue Capital Partners
Bourne Avenue Capital Partners is a real estate investment firm seeking opportunities to invest in real estate assets. We bring a wealth of sophisticated real estate and investment experience to the commercial real estate market.
Bouwinvest
Bouwinvest Real Estate Investors is a Dutch real estate investment firm founded in 1952. With over 72 years of experience, the company manages approximately €19 billion in capital from both Dutch and international institutional investors. Bouwinvest focuses on creating sustainable developments in the built environment, emphasizing a long-term vision and strong partnerships.
The firm operates specialized real estate funds across various sectors, including residential, retail, office, and healthcare. Notable properties in their portfolio include projects in major Dutch cities such as Amsterdam, Rotterdam, and Utrecht. Bouwinvest provides investment management services, connecting investor capital with ambitious real estate development projects to foster resilient urban areas.
Bowery Capital
Bowery Capital is an early-stage venture capital investor focused exclusively on founders looking to modernize business through technology. As more and more internet natives drive purchasing decisions, Bowery Capital believes that roughly $468B will change hands over the next 10 years as old products are replaced with new. In addition, the firm believes that the key ingredient to early success is revenue and customer growth, and as such provides various products and services through their Acceleration Team that portfolio companies can leverage to develop a strong early base. This combination of a focused thesis and support system are the cornerstones of Bowery Capital's investment approach
Bowmark Capital
Bowmark Capital is a private equity investment firm based in London, founded in 1997. The firm consists of a team of about 50 members, including experienced partners with an average tenure exceeding 10 years. Bowmark Capital is known for its focus on accelerating the growth of companies through collaborative partnerships with management teams, emphasizing integrity and diversity in its operations.
Bowmark Capital specializes in equity investments in the services and technology sectors, targeting growth companies valued up to £300 million. They make individual investments up to £200 million, focusing on areas such as Data and Insight, Managed IT Services, Software, and Tech-enabled Business Services. Overall, Bowmark Capital manages funds totaling £2 billion.
Some notable investments in Bowmark Capital's portfolio include ASK4 - a managed internet services provider, and Eque2 - a software provider for the construction industry. Bowmark Capital aims to support companies in leveraging long-term structural trends and pursuing strategies such as acquisitions, digital transformation, and international expansion.
Boxer Capital
Boxer Capital Management is a biotechnology investment firm based in San Diego, California. The firm is committed to research-based investing in specialized and precision medicine companies, both private and public. Boxer Capital is composed of a team of experienced scientists and investment professionals with nearly two decades of experience in life sciences and biotechnology sectors. Their approach is characterized by a combination of scientific expertise and investment acumen, allowing the firm to rigorously analyze and invest in promising medical advancements.
Boxer Capital targets investments across the drug life cycle, from early-stage innovation to late-stage development in biotechnology. They focus particularly on novel, transformative medical technologies with the potential to improve patient care significantly. The firm takes a disciplined, fundamental research approach to identify lucrative opportunities within the biotech ecosystem. They do not specify regular LPs or strategic partners, but their investments are global in scope.
Boxer Capital has been instrumental in the growth of several biotech companies, such as Pandion Therapeutics, Mirati Therapeutics, and Prometheus Biosciences. These companies represent a range of innovative medical treatments and novel drug targets that align with Boxer Capital's investment philosophy.